Back
Speaker illustration

Associate Professor Martin Bauer

Medical University of Vienna, Vienna (Austria)

Presentations

SAIT - Specific Active immunotherapy (SAIT) against PCSK9 is safe and lowers circulating LDL-C in humans

Event: ESC Congress 2018

Topic: Lipid-Lowering Agents

Session: Late Breaking Pharmacological Science

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources